跳至主要内容
临床试验/NCT01506700
NCT01506700终止不适用

Real Time Optical Coherence Tomography (OCT) of Human Tissue

Diagnostic Photonics, Inc.1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
5
试验地点
1
主要终点
The sensitivity and specificity of Optical Coherence Tomography to identify whether or not tumor can be identified ex vivo on breast cancer specimens as compared to post-surgical histology conclusions.

研究概览

简要总结

This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.

详细描述

This study is a single-center, prospective, two-part open label study of an optical imaging device on approximately twenty (20) subjects at one (1) study site. Patients scheduled to undergo a lumpectomy will be recruited by the clinical investigators at the investigational site in accordance with the inclusion and exclusion criteria. The study period per subject is the time it takes to assess the in vivo and ex vivo breast tissue samples using the study device during their lumpectomy.

All specimens will be marked with India ink and undergo standard post-operative histology, and digital histology images corresponding to the inked locations will be obtained. The images and the matched digitized post-operative histology images will then be randomized and read by a blinded, independent pathologist. Sensitivity and specificity will be calculated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women 18 years of age or older
  • Women who have been histologically diagnosed with invasive ductal carcinoma or invasive lobular carcinoma of the breast prior to surgery
  • Planning breast preservation
  • Patients undergoing lumpectomy (partial mastectomy) procedure

排除标准

  • Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)
  • Neoadjuvant systemic therapy
  • All T4 tumors
  • Previous radiation in the operated breast
  • Prior surgical procedure in the same quadrant
  • Implants in the operated breast
  • Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

结局指标

主要结局

The sensitivity and specificity of Optical Coherence Tomography to identify whether or not tumor can be identified ex vivo on breast cancer specimens as compared to post-surgical histology conclusions.

时间窗: One week after surgery

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验